Reports
Reports
CHANGING LIFESTYLES TO STOKE MORE GROWTH IN PHARMACEUTICALS
Total Reports: 482
The growth of the oral thin films market is substantial and driven by the alignment between patient-oriented innovations and the innovations in drug delivery technologies. One of the key market drivers is convenience as well as the ease of use of these films - which are especially advantageous to those
Rep Id : TMRGL42869 | Published | Pharmaceutical | June 2025
Nanotechnology drug delivery market is the pharmaceutical market that deals with research, manufacturing, and sales of drug delivery systems based on nanotechnology to deliver the therapeutic agents to the desired locations in the body. They are based on nanoscale carriers like nanoparticles, liposomes, or micelles to facilitate solubility, stabilization, targeting,
Rep Id : TMRGL86739 | Published | Pharmaceutical | June 2025
The active pharmaceutical ingredients (API) market is witnessing a robust growth. This could be attributed to increase in healthcare spending, growing incidences of infectious and chronic diseases, and rising demand for innovative and generic medicines.
Rep Id : TMRGL1690 | Published | Pharmaceutical | May 2025
Increased drug consumption and surge in clinical trials and outsourcing trends in pharma are significantly driving the pharmacovigilance industry demand. Pharmacovigilance involves the monitoring and evaluation of drug-related side effects, ensuring patient safety across all phases of the drug lifecycle.
Rep Id : TMRGL86696 | Published | Pharmaceutical | May 2025
The global topical pharmaceutical market is witnessing consistent growth owing to the increasing incidence rate of skin disorders, an aging population, and developments in drug delivery systems. Topical products in the form of creams, ointments, gels, and lotions provide localized therapy with fewer systemic side effects and are hence in
Rep Id : TMRGL86661 | Published | Pharmaceutical | May 2025
Development of innovative delivery technologies and advancements in medical expertise are expected to fuel the peptide therapeutics market size. PEGylation is a popular trend in the peptide drug chemical structure, which improves pharmacologic properties by increasing half-life, reducing antigenicity and immunogenicity, and improving solubility.
Rep Id : TMRGL418 | Published | Pharmaceutical | April 2025
The global acute kidney injury treatment market was valued at US$ 3.6 Bn in 2024 and is projected to reach US$ 8.2 Bn by 2035, registering a CAGR of 7.8% from 2025 to 2035. The market is driven by the growing incidence of kidney injuries due to rise in the
Rep Id : TMRGL67523 | Published | Pharmaceutical | April 2025
The market for stroke therapy as growth-promoting, driven by advancements in pharmacologic therapy and a better understanding of stroke pathophysiology. The sector is focusing more on the development of thrombolytic and antiplatelet medications, pivotal in acute stroke treatment for ischemic strokes. Drug delivery systems and formulation science are aiming at
Rep Id : TMRGL73917 | Published | Pharmaceutical | March 2025
Growing cost-efficiency and access to specialized expertise and global patient population are expected to boost clinical trials outsourcing market value. Since pharmaceutical and biotechnology firms strive to minimize operational costs, outsourcing is a cost-effective option.
Rep Id : TMRGL86540 | Published | Pharmaceutical | March 2025
Increase in demand for biopharmaceutical & biosimilar and growing adoption of single-use systems in pharmaceutical manufacturing is anticipated to boost water for injection market growth. Water for injection is extremely pure, sterile water employed in the manufacture of injectable pharmaceuticals, vaccines, and biologics to ensure drug safety and regulatory compliance.
Rep Id : TMRGL84885 | Published | Pharmaceutical | March 2025
Increase in awareness among healthcare professionals and patients regarding rare conditions such as alkaptonuria, ongoing technological advancements in genetic research, rising investments in research and development initiatives, and collaborative regulatory environment are the factors fueling the global alkaptonuria therapeutics market trajectory. Progress in bioanalytical assays and genetic testing has enabled
Rep Id : TMRGL86459 | Published | Pharmaceutical | February 2025
Rise in prevalence of lifestyle diseases and micronutrient deficiencies, increased heath awareness among consumers, expanding middle class with higher disposable incomes, and improved access to health products due to growth of internet platforms are factors driving the liposomal vitamins and minerals market growth in Africa.
Rep Id : TMRGL86453 | Published | Pharmaceutical | February 2025
Rapid technological advancements in targeted therapy and increase prevalence of cancer and various chronic diseases are some of the major factors driving kinase inhibitors market trajectory. The Kinase inhibitor market development is also driven by several key factors, including the increasing demand for personalized medicine, the rising incidence of cancer,
Rep Id : TMRGL818 | Published | Pharmaceutical | February 2025
Acute agitation and aggression constitute the fastest-emerging and most attractive industries in the world due to growing awareness about mental health issues and increasing prevalence of illnesses like schizophrenia and bipolar disorder. Several therapeutic approaches, including both - pharmacologic treatments and psychosocial interventions, are targeted and aimed at meeting these
Rep Id : TMRGL72345 | Published | Pharmaceutical | October 2024
Increased funding for R&D activities coupled with grants by government and non-government agencies regarding rare diseases (including nephropathic cystinosis) is crucial to changing the treatment landscape. This rise in financial resources lends great power to the efforts being made to develop new and effective treatments.
Rep Id : TMRGL32210 | Published | Pharmaceutical | August 2024
Growth in customer desire for natural and plant-derived components, especially in nutritional supplements and digestive health products, is bolstering the bromelain market growth. Bromelain, an enzyme extracted from pineapples, is widely utilized in the food industry due to its potent proteolytic activity.
Rep Id : TMRGL65423 | Published | Pharmaceutical | August 2024
Advances in biotechnology and better understanding of human microbiome is fueling the live biotherapeutics market growth.
Rep Id : TMRGL86353 | Published | Pharmaceutical | July 2024
Rise in geriatric population and influx of biologics are augmenting the paroxysmal nocturnal hemoglobinuria market demand. Paroxysmal nocturnal hemoglobinuria (PNH) is a chronic disorder affecting nearly 20,000 people across the globe.
Rep Id : TMRGL86343 | Published | Pharmaceutical | July 2024
The paresthesia treatment industry growth is slated to be witnessed based on rise in the number of patients suffering from neurological disorders along with adoption of technological advancements to combat the same.
Rep Id : TMRGL66734 | Published | Pharmaceutical | July 2024
Rise in the number of patients battling bad cholesterol is the factor augmenting the PCSK9 inhibitor market opportunities. Increase in incidence of cardiovascular diseases is another factor catalyzing the PCSK9 modulators landscape.
Rep Id : TMRGL83528 | Published | Pharmaceutical | July 2024
Increase in incidence of pancreatic cancer is the factor basically responsible for the growth of pancreatic cancer treatment market. Various technological advancements are being adopted to devise effective medications for pancreatic cancer, with radiation therapy being one of them.
Rep Id : TMRGL86342 | Published | Pharmaceutical | July 2024
Growing investment as well as funding by governments and non-government agencies worldwide to exercise control over opioid overdose is the factor basically responsible for the growth of opioid use disorders market.
Rep Id : TMRGL75167 | Published | Pharmaceutical | July 2024
Easy administration and wider patient compliance are responsible for the growth of the oral solid dosage pharmaceutical formulation market. Moreover, lesser cost associated with the production and dispersion of these formulations makes them viable for the patients.
Rep Id : TMRGL80675 | Published | Pharmaceutical | July 2024
The global non-muscle invasive bladder cancer market is slated to grow noticeably on the basis of rise in the number of patients suffering from non-muscle invasive bladder cancer along with governments extensively investing in qualitative research pertaining to therapeutics for non-muscle invasive bladder cancer.
Rep Id : TMRGL86334 | Published | Pharmaceutical | July 2024
The global non-insulin therapies for diabetes market is slated to grow on an exponential note with a sizable increase in incidence of type 2 diabetes followed by governments and non-government agencies collaborating to devise better measures to cure it, with non-insulin therapies being the epicenter.
Rep Id : TMRGL86328 | Published | Pharmaceutical | July 2024
Rise in incidence of cardiovascular diseases and insomnia are the factors responsible for the augmentation of nocturia market. Various conditions affecting the bladder/prostate can result in having to wake up to urinate.
Rep Id : TMRGL49929 | Published | Pharmaceutical | July 2024
The global neuroregeneration therapy market is slated to grow on an exponential note due to rise in the incidence of neurological disorders followed by extensive R&D activities being witnessed on the therapeutics count.
Rep Id : TMRGL86322 | Published | Pharmaceutical | July 2024
Rise in the number of patients suffering from non-Hodgkin’s lymphoma is the factor responsible for the growth of non-Hodgkin’s lymphoma therapeutics market.
Rep Id : TMRGL2668 | Published | Pharmaceutical | July 2024
Rise in the incidence of chronic diseases is the factor basically augmenting the natural APIs market. Active pharmaceutical ingredients (APIs) play a crucial role in human therapeutics, as they account for close to 20% of secondary metabolites.
Rep Id : TMRGL86321 | Published | Pharmaceutical | July 2024
Rise in the number of patients suffering from myocarditis is the factor basically responsible for the growth of myocarditis treatment market. Myocarditis is referred to as inflammation of heart muscle caused owing to autoimmune diseases.
Rep Id : TMRGL86316 | Published | Pharmaceutical | July 2024
Most comprehensive coverage 100+ countries, 2 million+ data points
Personalized pre-sales, on-boarding, and post-sales support
Less assumption, more science - a research methodology perfected through years of rigorous diligence
True to its name, transparency in every minute details from research processes to financials
20% of Fortune 500 are our clients have worked with over 3000 SMEs
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
